| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.291 | 15.895 | 17.614 | 21.013 | 26.421 | 10.483 | -598 | 48.417 | 113.332 | 112.555 |
| Total Income - EUR | 11.291 | 15.895 | 17.614 | 21.013 | 26.424 | 11.093 | -598 | 48.419 | 113.334 | 112.557 |
| Total Expenses - EUR | 5.761 | 6.378 | 7.183 | 11.625 | 15.517 | 14.574 | 7.979 | 31.138 | 81.145 | 91.272 |
| Gross Profit/Loss - EUR | 5.530 | 9.517 | 10.431 | 9.387 | 10.907 | -3.481 | -8.577 | 17.281 | 32.189 | 21.285 |
| Net Profit/Loss - EUR | 5.192 | 9.040 | 10.049 | 9.177 | 10.642 | -3.587 | -8.577 | 16.890 | 31.176 | 18.314 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 |
Check the financial reports for the company - Ocuvision Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.700 | 3.876 | 5.524 | 5.603 | 5.083 | 3.977 | 3.488 | 148.682 | 132.118 | 76.551 |
| Current Assets | 1.269 | 8.990 | 18.189 | 23.167 | 24.098 | 22.520 | 11.808 | 27.263 | 48.728 | 41.052 |
| Inventories | 0 | 0 | 960 | 600 | 331 | 0 | 0 | 220 | 876 | 14 |
| Receivables | 0 | 0 | 0 | 0 | 2.158 | 3.280 | 920 | 11.876 | 11.132 | 986 |
| Cash | 1.269 | 8.990 | 17.228 | 22.567 | 21.609 | 19.240 | 10.888 | 15.166 | 36.721 | 40.052 |
| Shareholders Funds | 3.598 | 12.602 | 13.551 | 22.479 | 27.734 | 23.621 | 14.520 | 31.455 | 66.754 | 76.158 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 370 | 318 | 10.165 | 6.290 | 1.447 | 2.876 | 777 | 144.490 | 114.092 | 41.624 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ocuvision Srl